Federal Circuit Affirms Invalidation Of CRISPR Patents As Anticipated
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on June 11 said there was no error in the U.S. Patent Trial and Appeal Board’s (PTAB) finding that all...To view the full article, register now.
Already a subscriber? Click here to view full article